The specific class of gadolinium-based contrast agents (GBCAs) used in prior contrast-enhanced MRI is a determining factor in whether patients exhibit heightened signal intensity on unenhanced T1-weighted MR images, according to study results published online April 6 in the journal Radiology.

ROCHESTER, N.Y., April 15 — Carestream earned the top rating in MD Buyline’s Market Intelligence Briefing™ (2015 Q1) for both portable and room-based DR systems. Carestream’s DRX-Revolution Mobile X-ray Systemand its DRX-Evolution and DRX-Ascend systems earned high marks from customers for system performance, reliability, installation and service repair quality. The DRX-Revolution was the highest rated portable system and Carestream’s DRX room-based platform tied for the highest rating in the DR room category. 

Siemens Healthcare has launched its new portable and compact ACUSON P500TM ultrasound system, FROSK edition, enabling rapid imaging even in difficult scanning conditions. The hand-held technology can be easily carried and positioned in a range of clinical environments and is ready to image in less than 30 seconds, making it ideal for emergency settings. The system introduces two new advanced technologies that ensure sharp ultrasound images, regardless of patient and probe motion.

For some, cracking their knuckles is a nervous habit or part of a stretch routine during the workday. Others are sure it must cause damage or lead to arthritis. But until recently, nobody was certain about how the noise was even created. A team of researchers turned to MRI for the answer.

Not all mammography screening facilities are created equal. A recent study into the characteristics of various facilities across the country found women who seek screening at multispecialty breast centers or full diagnostic radiology practices are more likely to also have advanced breast imaging services at the same location compared with women who go to nonradiology or breast imaging-only practices.

The Centers for Medicare & Medicaid Services (CMS) has issued a notice correcting the 2015 MPFS Final Rule, asking providers who perform diagnostic digital breast tomosynthesis without performing accompanying 2D mammography to still code for both procedures.

The national costs of false-positive mammograms and breast cancer overdiagnoses clock in at an estimated $4 billion per year, according to a study published in the April issue of Health Affairs.

Breast density notification and related legislation is gaining momentum due to the risks associated with dense breast tissue. But how much do women know about their own breast densities? Check out this infographic to find out.